Alder Biopharmaceuticals Lands $80,000,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8bb3b7ad-213e-43b9-a2d8-f817664e4d22
Date
5/8/2014
Company Name
Alder Biopharmaceuticals
Mailing Address
11804 North Creek Parkway South Bothell, WA 98011 USA
Company Description
Alder Biopharmaceuticals (NASDAQ: ALDR) uniquely identifies, develops, and manufactures novel antibody therapeutics to alleviate human suffering in the autoimmune and inflammatory disease areas. Alder’s management team combines decades of industry experience with a proven track record for identifying and developing novel antibody therapeutics.
Website
http://www.alderbio.com
Transaction Type
IPO
Transaction Amount
$80,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes are on file with company statements at the SEC.
M&A Terms